These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 16441474

  • 1. Validation of a symptom diary for patients with gastro-oesophageal reflux disease.
    Puhan MA, Guyatt GH, Armstrong D, Wiklund I, Fallone CA, Heels-Ansdell D, Degl'Innocenti A, Veldhuyzen van Zanten SJ, Tanser L, Barkun AN, Chiba N, Austin P, El-Dika S, Schünemann HJ.
    Aliment Pharmacol Ther; 2006 Feb 15; 23(4):531-41. PubMed ID: 16441474
    [Abstract] [Full Text] [Related]

  • 2. Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease.
    Pace F, Negrini C, Wiklund I, Rossi C, Savarino V, ITALIAN ONE INVESTIGATORS STUDY GROUP.
    Aliment Pharmacol Ther; 2005 Aug 15; 22(4):349-56. PubMed ID: 16098002
    [Abstract] [Full Text] [Related]

  • 3. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
    Johnson D, Crawley JA, Hwang C, Brown K.
    Aliment Pharmacol Ther; 2010 Jul 15; 32(2):182-90. PubMed ID: 20456306
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
    Wada T, Sasaki M, Kataoka H, Tanida S, Itoh K, Ogasawara N, Oshima T, Togawa S, Kubota E, Yamada T, Mori Y, Fujita F, Ohara H, Nakao H, Sobue S, Joh T, Itoh M.
    Aliment Pharmacol Ther; 2005 Jun 15; 21 Suppl 2():2-9. PubMed ID: 15943840
    [Abstract] [Full Text] [Related]

  • 5. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
    Aanen MC, Weusten BL, Numans ME, de Wit NJ, Samsom M, Smout AJ.
    J Clin Gastroenterol; 2008 Jun 15; 42(5):441-7. PubMed ID: 18344896
    [Abstract] [Full Text] [Related]

  • 6. Sleep dysfunction in patients with gastro-oesophageal reflux disease: prevalence and response to GERD therapy, a pilot study.
    Chand N, Johnson DA, Tabangin M, Ware JC.
    Aliment Pharmacol Ther; 2004 Nov 01; 20(9):969-74. PubMed ID: 15521844
    [Abstract] [Full Text] [Related]

  • 7. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.
    Malfertheiner P, Nocon M, Vieth M, Stolte M, Jaspersen D, Koelz HR, Labenz J, Leodolter A, Lind T, Richter K, Willich SN.
    Aliment Pharmacol Ther; 2012 Jan 01; 35(1):154-64. PubMed ID: 22070159
    [Abstract] [Full Text] [Related]

  • 8. Do physicians correctly assess patient symptom severity in gastro-oesophageal reflux disease?
    Fallone CA, Guyatt GH, Armstrong D, Wiklund I, Degl'Innocenti A, Heels-Ansdell D, Barkun AN, Chiba N, Zanten SJ, El-Dika S, Austin P, Tanser L, Schünemann HJ.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1161-9. PubMed ID: 15569119
    [Abstract] [Full Text] [Related]

  • 9. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
    Johnson DA, Orr WC, Crawley JA, Traxler B, McCullough J, Brown KA, Roth T.
    Am J Gastroenterol; 2005 Sep 15; 100(9):1914-22. PubMed ID: 16128933
    [Abstract] [Full Text] [Related]

  • 10. Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire.
    van Zanten SV, Armstrong D, Barkun A, Junghard O, White RJ, Wiklund IK.
    Aliment Pharmacol Ther; 2007 May 01; 25(9):1087-97. PubMed ID: 17439510
    [Abstract] [Full Text] [Related]

  • 11. Validation of a four-graded scale for severity of heartburn in patients with symptoms of gastroesophageal reflux disease.
    Junghard O, Wiklund I.
    Value Health; 2008 May 01; 11(4):765-70. PubMed ID: 18194395
    [Abstract] [Full Text] [Related]

  • 12. Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease.
    Gold BD, Gunasekaran T, Tolia V, Wetzler G, Conter H, Traxler B, Illueca M.
    J Pediatr Gastroenterol Nutr; 2007 Nov 01; 45(5):520-9. PubMed ID: 18030228
    [Abstract] [Full Text] [Related]

  • 13. Concomitant symptoms itemized in the Reflux Disease Questionnaire are associated with attenuated heartburn response to acid suppression.
    Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW.
    Am J Gastroenterol; 2012 Sep 01; 107(9):1354-60. PubMed ID: 22777339
    [Abstract] [Full Text] [Related]

  • 14. Effect of baseline symptom severity on patient-reported outcomes in gastroesophageal reflux disease.
    Junghard O, Wiklund IK.
    Eur J Gastroenterol Hepatol; 2007 Jul 01; 19(7):555-60. PubMed ID: 17556901
    [Abstract] [Full Text] [Related]

  • 15. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
    Rush DR, Stelmach WJ, Young TL, Kirchdoerfer LJ, Scott-Lennox J, Holverson HE, Sabesin SM, Nicholas TA.
    J Fam Pract; 1995 Aug 01; 41(2):126-36. PubMed ID: 7636452
    [Abstract] [Full Text] [Related]

  • 16. Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study.
    Nocon M, Labenz J, Jaspersen D, Leodolter A, Richter K, Vieth M, Lind T, Malfertheiner P, Willich SN.
    Aliment Pharmacol Ther; 2009 Mar 15; 29(6):662-8. PubMed ID: 19183146
    [Abstract] [Full Text] [Related]

  • 17. Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD.
    Brozek JL, Guyatt GH, Heels-Ansdell D, Degl'Innocenti A, Armstrong D, Fallone CA, Wiklund I, van Zanten SV, Chiba N, Barkun AN, Akl EA, Schünemann HJ.
    J Clin Epidemiol; 2009 Jan 15; 62(1):102-10. PubMed ID: 18619804
    [Abstract] [Full Text] [Related]

  • 18. Correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease.
    Sarnelli G, De Giorgi F, Efficie E, Aprea G, Masone S, Savarese MF, Esposito I, Russo L, Cuomo R.
    Eur J Gastroenterol Hepatol; 2008 Apr 15; 20(4):264-8. PubMed ID: 18334868
    [Abstract] [Full Text] [Related]

  • 19. International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease.
    Bardhan KD, Stanghellini V, Armstrong D, Berghöfer P, Gatz G, Mönnikes H.
    Digestion; 2007 Apr 15; 75 Suppl 1():48-54. PubMed ID: 17489032
    [Abstract] [Full Text] [Related]

  • 20. Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
    Frazzoni M, Manno M, De Micheli E, Savarino V.
    Dig Liver Dis; 2006 Feb 15; 38(2):85-90. PubMed ID: 16289976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.